Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PREPARE: Botulinum Toxin for Prevention of Post-surgical Pancreatic Fistula
NCT04220931Phase 3Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Mar 2023
- Primary completion
- Dec 2026
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in pancreatic fistula (POPF), sponsored by Assistance publique - Hôpitaux de Paris. Started Mar 2023; status: recruiting.
02
Drugs
botulinum toxin type A
03
Conditions
pancreatic fistula (POPF)
Beyond the preview
Go deeper on NCT04220931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04220931.